MEVALAB: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEVALAB
Largest movements
- Stocks and contracts -€9,150
down €9,150 (-84.6%), from €10,814 to €1,664
- Receivables within one year -€2,956
down €2,956 (-26.7%), from €11,057 to €8,101
of which Trade receivables: -€2,849
- Tangible fixed assets +€811
new in 2025: €811
- Cash +€401
up €401 (+32.2%), from €1,245 to €1,646
mainly Stocks and contracts (+€9,150) and Other debts (+€7,920)
- Profit (loss) carried forward -€12,960
down €12,960 (-52.6%), from -€24,621 to -€37,581
- Other debts +€7,920
up €7,920 (+23.1%), from €34,278 to €42,198
- Trade debts -€6,207
down €6,207 (-93.5%), from €6,639 to €432
- Tax, wage and social debts +€353
new in 2025: €353
- Gross operating margin -€18,348
down €18,348, from €5,460 to -€12,888
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €23,116 | €12,222 | -€10,894 | -47.1% |
| Fixed assets | 21/28 | - | €811 | +€811 | |
| Tangible fixed assets | 22/27 | - | €811 | +€811 | |
| Plant, machinery and equipment | 23 | - | €811 | +€811 | |
| Current assets | 29/58 | €23,116 | €11,411 | -€11,705 | -50.6% |
| Stocks and contracts in progress | 3 | €10,814 | €1,664 | -€9,150 | -84.6% |
| Stocks | 30/36 | €10,814 | €1,664 | -€9,150 | -84.6% |
| Amounts receivable within one year | 40/41 | €11,057 | €8,101 | -€2,956 | -26.7% |
| Trade receivables | 40 | €10,949 | €8,100 | -€2,849 | -26.0% |
| Other amounts receivable | 41 | €108 | €1 | -€107 | -99.1% |
| Cash at bank and in hand | 54/58 | €1,245 | €1,646 | +€401 | +32.2% |
| Total equity and liabilities | 10/49 | €23,116 | €12,222 | -€10,894 | -47.1% |
| Equity | 10/15 | -€17,801 | -€30,761 | -€12,960 | -72.8% |
| Contributions | 10/11 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €620 | €620 | = | 0.0% |
| Non-distributable reserves | 130/1 | €620 | €620 | = | 0.0% |
| Reserves not available under the articles | 1311 | €620 | €620 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€24,621 | -€37,581 | -€12,960 | -52.6% |
| Amounts payable | 17/49 | €40,917 | €42,983 | +€2,066 | +5.0% |
| Amounts payable within one year | 42/48 | €40,917 | €42,983 | +€2,066 | +5.0% |
| Trade debts | 44 | €6,639 | €432 | -€6,207 | -93.5% |
| Suppliers | 440/4 | €6,639 | €432 | -€6,207 | -93.5% |
| Taxes, remuneration and social security | 45 | - | €353 | +€353 | |
| Taxes | 450/3 | - | €353 | +€353 | |
| Other amounts payable | 47/48 | €34,278 | €42,198 | +€7,920 | +23.1% |
| Gross operating margin | 9900 | €5,460 | -€12,888 | -€18,348 | |
| Operating profit (loss) | 9901 | €5,460 | -€12,888 | -€18,348 | |
| Financial income | 75/76B | €19 | €95 | +€76 | +400.0% |
| Recurring financial income | 75 | €19 | €95 | +€76 | +400.0% |
| Financial charges | 65/66B | €249 | €167 | -€82 | -32.9% |
| Recurring financial charges | 65 | €249 | €167 | -€82 | -32.9% |
| Profit (loss) for the period before taxes | 9903 | €5,230 | -€12,960 | -€18,190 | |
| Profit (loss) for the period | 9904 | €5,230 | -€12,960 | -€18,190 | |
| Profit (loss) for the period to be appropriated | 9905 | €5,230 | -€12,960 | -€18,190 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 8 October 2026 via checked.be.